Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACIU
#6081
AC Immune SA
2.9
3
-0.34%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-0.34%
Aylık değişim
-17.93%
6 aylık değişim
+42.23%
Yıllık değişim
+14.45%
Önceki kapanış
2.9
4
Open
2.9
3
Bid
Ask
Low
2.9
3
High
2.9
3
Hacim
17
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ACIU
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
100.41 M
366.71 M
Valuation ratios
Enterprise value
271.11 M
1.33 B
Price to earnings ratio
—
—
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Haberler
AC Immune inicia ensayo de fase 1 de inhibidor NLRP3 penetrante cerebral
AC Immune inicia ensayo fase 1 de inhibidor NLRP3 que penetra cerebro
AC Immune begins phase 1 trial of brain-penetrant NLRP3 inhibitor
2026 Market Outlook: Focus On Pharma For Consistent Returns, Potential Skyrocketing Shares
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD
Tesla and Rivian among market cap stock movers on Friday
AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - AC Immune (NASDAQ:ACIU)
Las acciones de AC Immune suben tras datos positivos de ensayo para Parkinson
Acciones de AC Immune suben tras datos positivos en ensayo de Parkinson
AC Immune stock rises after positive Parkinson’s disease trial data
El tratamiento para el Parkinson de AC Immune muestra promesas en frenar la enfermedad
Tratamiento de AC Immune para Parkinson muestra promesa en frenar la enfermedad